David Tuck | Profiles RNS

David Tuck, MD

Clinical Associate Professor

Boston University Chobanian & Avedisian School of Medicine

Medicine

Hematology & Medical Oncology

MD, University of Vermont College of Medicine
AB, Harvard College

Websites

	LinkedIn
	ResearchGate

Publications
Contact Info

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

La J, Lee MH, Brophy MT, Do NV, Driver JA, Tuck DP, Fillmore NR, Dumontier C. Baseline correlates of frailty and its association with survival in United States veterans with acute myeloid leukemia. Leuk Lymphoma. 2023 Dec; 64(13):2081-2090.View Related Profiles.

Tuck, David
La, Jennifer
Brophy, Mary
Fillmore, Nathanael

PMID: 37671705

Lin E, Zwolinski R, Wu JT, La J, Goryachev S, Huhmann L, Yildrim C, Tuck DP, Elbers DC, Brophy MT, Do NV, Fillmore NR. Machine learning-based natural language processing to extract PD-L1 expression levels from clinical notes. Health Informatics J. 2023; 29(3):14604582231198021.View Related Profiles.

Elbers, Danne
Tuck, David
La, Jennifer
Brophy, Mary
Fillmore, Nathanael

PMID: 37635280

Cheng D, Dumontier C, Sheikh AR, La J, Brophy MT, Do NV, Driver JA, Tuck DP, Fillmore NR. Prognostic value of the veterans affairs frailty index in older patients with non-small cell lung cancer. Cancer Med. 2022 Aug; 11(15):3009-3022.View Related Profiles.

Tuck, David
La, Jennifer
Brophy, Mary
Fillmore, Nathanael
Van Do, Nhan

PMID: 35338613; PMCID: PMC9359868; DOI: 10.1002/cam4.4658;

Katabathula R, Joseph P, Singh S, Zhao S, Kumar B, Gaule P, Pan Q, Old M, Tuck DP, Varadan V. Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer. Clin Cancer Res. 2022 03 01; 28(5):984-992. PMID: 34785584

Tuck D. A cancer graph: a lung cancer property graph database in Neo4j. BMC Res Notes. 2022 Feb 14; 15(1):45. PMID: 35164854; PMCID: PMC8842806; DOI: 10.1186/s13104-022-05912-9;

Wu JT, La J, Branch-Elliman W, Huhmann LB, Han SS, Parmigiani G, Tuck DP, Brophy MT, Do NV, Lin AY, Munshi NC, Fillmore NR. Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs Study. JAMA Oncol. 2022 02 01; 8(2):281-286.View Related Profiles.

Tuck, David
La, Jennifer
Brophy, Mary
Fillmore, Nathanael
Van Do, Nhan
Munshi, Nikhil C.
Branch-Elliman, Westyn

PMID: 34854921; PMCID: PMC8640949; DOI: 10.1001/jamaoncol.2021.5771;

Erbe R, Wang Z, Wu S, Xiu J, Zaidi N, La J, Tuck D, Fillmore N, Giraldo NA, Topper M, Baylin S, Lippman M, Isaacs C, Basho R, Serebriiskii I, Lenz HJ, Astsaturov I, Marshall J, Taverna J, Lee J, Jaffee EM, Roussos Torres ET, Weeraratna A, Easwaran H, Fertig EJ. Evaluating the impact of age on immune checkpoint therapy biomarkers. Cell Rep. 2021 Nov 16; 37(7):110033.View Related Profiles.

Tuck, David
La, Jennifer
Fillmore, Nathanael

PMID: 34788629

Tuck, David
La, Jennifer
Fillmore, Nathanael

PMID: 34433020; PMCID: PMC8757482; DOI: 10.1016/j.celrep.2021.109599;

Fillmore NR, La J, Szalat RE, Tuck DP, Nguyen V, Yildirim C, Do NV, Brophy MT, Munshi NC. Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study. J Natl Cancer Inst. 2021 06 01; 113(6):691-698.View Related Profiles.

Tuck, David
La, Jennifer
Brophy, Mary
Fillmore, Nathanael
Van Do, Nhan
Munshi, Nikhil C.
Szalat, Raphael

PMID: 33031532; PMCID: PMC7665587; DOI: 10.1093/jnci/djaa159;

La J, Cheng D, Brophy MT, Do NV, Lee JSH, Tuck D, Fillmore NR. Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs System. JCO Clin Cancer Inform. 2020 10; 4:918-928.View Related Profiles.

Tuck, David
La, Jennifer
Brophy, Mary
Fillmore, Nathanael
Van Do, Nhan

PMID: 33074743; PMCID: PMC7608595; DOI: 10.1200/CCI.20.00084;

Showing 10 of 75 results. Show More

Cheng D, Ramos-Cejudo J, Tuck D, Elbers D, Brophy M, Do N, Fillmore N. External validation of a prognostic model for mortality among patients with non-small-cell lung cancer using the Veterans Precision Oncology Data Commons. Semin Oncol. 2019 Aug - Oct; 46(4-5):327-333.View Related Profiles.

Elbers, Danne
Tuck, David
Brophy, Mary
Fillmore, Nathanael
Van Do, Nhan

PMID: 31708233

Do N, Grossman R, Feldman T, Fillmore N, Elbers D, Tuck D, Dhond R, Selva L, Meng F, Fitzsimons M, Ajjarapu S, Ayandeh S, Hall R, Do S, Brophy M. The Veterans Precision Oncology Data Commons: Transforming VA data into a national resource for research in precision oncology. Semin Oncol. 2019 Aug - Oct; 46(4-5):314-320.View Related Profiles.

Elbers, Danne
Tuck, David
Meng, Frank
Selva, Luis
Brophy, Mary
Fillmore, Nathanael
Van Do, Nhan
Dhond, Rupali

PMID: 31629530

Oki Y, Kelly KR, Flinn I, Patel MR, Gharavi R, Ma A, Parker J, Hafeez A, Tuck D, Younes A. CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial. Haematologica. 2017 11; 102(11):1923-1930. PMID: 28860342; PMCID: PMC5664396; DOI: 10.3324/haematol.2017.172882;

Adusumilli PS, Cha E, Cornfeld M, Davis T, Diab A, Dubensky TW, Evans E, Grogan JL, Irving BA, Leidner RS, Olwill SA, Soon-Shiong P, Triebel F, Tuck D, Bot A, Dansey RD, Drake CG, Freeman GJ, Ibrahim R, Patel S, Chen DS. New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016. J Immunother Cancer. 2017; 5:50. PMID: 28649381; PMCID: PMC5477277; DOI: 10.1186/s40425-017-0253-2;

Sun K, Atoyan R, Borek MA, Dellarocca S, Samson ME, Ma AW, Xu GX, Patterson T, Tuck DP, Viner JL, Fattaey A, Wang J. Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers. Mol Cancer Ther. 2017 02; 16(2):285-299. PMID: 27980108

Nemec AA, Bush KB, Towle-Weicksel JB, Taylor BF, Schulz V, Weidhaas JB, Tuck DP, Sweasy JB. Estrogen Drives Cellular Transformation and Mutagenesis in Cells Expressing the Breast Cancer-Associated R438W DNA Polymerase Lambda Protein. Mol Cancer Res. 2016 11; 14(11):1068-1077. PMID: 27621267; PMCID: PMC5107123; DOI: 10.1158/1541-7786.MCR-16-0209;

Goel S, Wang Q, Watt AC, Tolaney SM, Dillon DA, Li W, Ramm S, Palmer AC, Yuzugullu H, Varadan V, Tuck D, Harris LN, Wong KK, Liu XS, Sicinski P, Winer EP, Krop IE, Zhao JJ. Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors. Cancer Cell. 2016 Mar 14; 29(3):255-269. PMID: 26977878; PMCID: PMC4794996; DOI: 10.1016/j.ccell.2016.02.006;

Varadan V, Gilmore H, Miskimen KL, Tuck D, Parsai S, Awadallah A, Krop IE, Winer EP, Bossuyt V, Somlo G, Abu-Khalaf MM, Fenton MA, Sikov W, Harris LN. Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer. Clin Cancer Res. 2016 07 01; 22(13):3249-59. PMID: 26842237; PMCID: PMC5439498; DOI: 10.1158/1078-0432.CCR-15-2021;

Abu-Khalaf MM, Baumgart MA, Gettinger SN, Doddamane I, Tuck DP, Hou S, Chen N, Sullivan C, Lezon-Geyda K, Zelterman D, Hatzis C, Deshpande H, Digiovanna MP, Azodi M, Schwartz PE, Harris LN. Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors. Cancer. 2015 Jun 01; 121(11):1817-26. PMID: 25649370

Shahabi V, Postow MA, Tuck D, Wolchok JD. Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy. Am J Clin Oncol. 2015 Feb; 38(1):90-7. PMID: 25616204

Canaan A, DeFuria J, Perelman E, Schultz V, Seay M, Tuck D, Flavell RA, Snyder MP, Obin MS, Weissman SM. Extended lifespan and reduced adiposity in mice lacking the FAT10 gene. Proc Natl Acad Sci U S A. 2014 Apr 8; 111(14):5313-8.View Related Profiles.

Tuck, David
Defuria, Jason

PMID: 24706839; PMCID: PMC3986194; DOI: 10.1073/pnas.1323426111;

Lindner R, Sullivan C, Offor O, Lezon-Geyda K, Halligan K, Fischbach N, Shah M, Bossuyt V, Schulz V, Tuck DP, Harris LN. Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy. PLoS One. 2013; 8(11):e71915. PMID: 24260093; PMCID: PMC3832509; DOI: 10.1371/journal.pone.0071915;

Kamalakaran S, Varadan V, Janevski A, Banerjee N, Tuck D, McCombie WR, Dimitrova N, Harris LN. Translating next generation sequencing to practice: opportunities and necessary steps. Mol Oncol. 2013 Aug; 7(4):743-55. PMID: 23769412; PMCID: PMC5528427; DOI: 10.1016/j.molonc.2013.04.008;

Kim YJ, Greer CB, Cecchini KR, Harris LN, Tuck DP, Kim TH. HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade. Oncogene. 2013 Jun 06; 32(23):2828-35. PMID: 23435418; PMCID: PMC3676447; DOI: 10.1038/onc.2013.32;

Martín M, Prat A, Rodríguez-Lescure A, Caballero R, Ebbert MT, Munárriz B, Ruiz-Borrego M, Bastien RR, Crespo C, Davis C, Rodríguez CA, López-Vega JM, Furió V, García AM, Casas M, Ellis MJ, Berry DA, Pitcher BN, Harris L, Ruiz A, Winer E, Hudis C, Stijleman IJ, Tuck DP, Carrasco E, Perou CM, Bernard PS. PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer. Breast Cancer Res Treat. 2013 Apr; 138(2):457-66. PMID: 23423445; PMCID: PMC3608881; DOI: 10.1007/s10549-013-2416-2;

Neumeister VM, Sullivan CA, Lindner R, Lezon-Geyda K, Li J, Zavada J, Martel M, Glazer PM, Tuck DP, Rimm DL, Harris L. Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer. Breast Cancer Res Treat. 2012 Nov; 136(1):67-75. PMID: 22976806

Donigan KA, Tuck D, Schulz V, Sweasy JB. DNA polymerase ß variant Ile260Met generates global gene expression changes related to cellular transformation. Mutagenesis. 2012 Nov; 27(6):683-91. PMID: 22914675; PMCID: PMC3611876; DOI: 10.1093/mutage/ges034;

Mu L, Tuck D, Katsaros D, Lu L, Schulz V, Perincheri S, Menato G, Scarampi L, Harris L, Yu H. Favorable outcome associated with an IGF-1 ligand signature in breast cancer. Breast Cancer Res Treat. 2012 May; 133(1):321-31. PMID: 22297468

Wu JQ, Seay M, Schulz VP, Hariharan M, Tuck D, Lian J, Du J, Shi M, Ye Z, Gerstein M, Snyder MP, Weissman S. Tcf7 is an important regulator of the switch of self-renewal and differentiation in a multipotential hematopoietic cell line. PLoS Genet. 2012; 8(3):e1002565. PMID: 22412390; PMCID: PMC3297581; DOI: 10.1371/journal.pgen.1002565;

Lin W, Cao J, Liu J, Beshiri ML, Fujiwara Y, Francis J, Cherniack AD, Geisen C, Blair LP, Zou MR, Shen X, Kawamori D, Liu Z, Grisanzio C, Watanabe H, Minamishima YA, Zhang Q, Kulkarni RN, Signoretti S, Rodig SJ, Bronson RT, Orkin SH, Tuck DP, Benevolenskaya EV, Meyerson M, Kaelin WG, Yan Q. Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1. Proc Natl Acad Sci U S A. 2011 Aug 16; 108(33):13379-86. PMID: 21788502; PMCID: PMC3158206; DOI: 10.1073/pnas.1110104108;

Chan E, Patel R, Nallur S, Ratner E, Bacchiocchi A, Hoyt K, Szpakowski S, Godshalk S, Ariyan S, Sznol M, Halaban R, Krauthammer M, Tuck D, Slack FJ, Weidhaas JB. MicroRNA signatures differentiate melanoma subtypes. Cell Cycle. 2011 Jun 01; 10(11):1845-52. PMID: 21543894; PMCID: PMC3233487; DOI: 10.4161/cc.10.11.15777;

Wilson KA, Colavito SA, Schulz V, Wakefield PH, Sessa W, Tuck D, Stern DF. NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53. Mol Cancer Res. 2011 Jun; 9(6):766-81. PMID: 21551225; PMCID: PMC3901581; DOI: 10.1158/1541-7786.MCR-10-0317;

Paranjape T, Heneghan H, Lindner R, Keane FK, Hoffman A, Hollestelle A, Dorairaj J, Geyda K, Pelletier C, Nallur S, Martens JW, Hooning MJ, Kerin M, Zelterman D, Zhu Y, Tuck D, Harris L, Miller N, Slack F, Weidhaas J. A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis. Lancet Oncol. 2011 Apr; 12(4):377-86. PMID: 21435948; PMCID: PMC3488438; DOI: 10.1016/S1470-2045(11)70044-4;

Daigle D, Gradoville L, Tuck D, Schulz V, Wang'ondu R, Ye J, Gorres K, Miller G. Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle. J Virol. 2011 Jun; 85(11):5628-43. PMID: 21411522; PMCID: PMC3094991; DOI: 10.1128/JVI.02659-10;

Li A, Liu Z, Lezon-Geyda K, Sarkar S, Lannin D, Schulz V, Krop I, Winer E, Harris L, Tuck D. GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays. Nucleic Acids Res. 2011 Jul; 39(12):4928-41. PMID: 21398628; PMCID: PMC3130254; DOI: 10.1093/nar/gkr014;

Isern J, He Z, Fraser ST, Nowotschin S, Ferrer-Vaquer A, Moore R, Hadjantonakis AK, Schulz V, Tuck D, Gallagher PG, Baron MH. Single-lineage transcriptome analysis reveals key regulatory pathways in primitive erythroid progenitors in the mouse embryo. Blood. 2011 May 05; 117(18):4924-34. PMID: 21263157; PMCID: PMC3100699; DOI: 10.1182/blood-2010-10-313676;

Tuck DP, Miranker W. Modeling the clonal heterogeneity of stem cells. Theor Biol Med Model. 2010 Nov 17; 7:44. PMID: 21083923; PMCID: PMC2998476; DOI: 10.1186/1742-4682-7-44;

Ratner ES, Tuck D, Richter C, Nallur S, Patel RM, Schultz V, Hui P, Schwartz PE, Rutherford TJ, Weidhaas JB. MicroRNA signatures differentiate uterine cancer tumor subtypes. Gynecol Oncol. 2010 Sep; 118(3):251-7. PMID: 20542546; PMCID: PMC2918705; DOI: 10.1016/j.ygyno.2010.05.010;

Liu Z, Li A, Schulz V, Chen M, Tuck D. MixHMM: inferring copy number variation and allelic imbalance using SNP arrays and tumor samples mixed with stromal cells. PLoS One. 2010 Jun 01; 5(6):e10909. PMID: 20532221; PMCID: PMC2879364; DOI: 10.1371/journal.pone.0010909;

Lee HM, Zhang H, Schulz V, Tuck DP, Forget BG. Downstream targets of HOXB4 in a cell line model of primitive hematopoietic progenitor cells. Blood. 2010 Aug 05; 116(5):720-30. PMID: 20404135; PMCID: PMC2918329; DOI: 10.1182/blood-2009-11-253872;

Daigle D, Megyola C, El-Guindy A, Gradoville L, Tuck D, Miller G, Bhaduri-McIntosh S. Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors. J Virol. 2010 Jan; 84(2):993-1004. PMID: 19889776; PMCID: PMC2798381; DOI: 10.1128/JVI.01745-09;

Brandsma JL, Sun Y, Lizardi PM, Tuck DP, Zelterman D, Haines GK, Martel M, Harigopal M, Schofield K, Neapolitano M. Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology. 2009 Jun 20; 389(1-2):100-7. PMID: 19443004; PMCID: PMC2918277; DOI: 10.1016/j.virol.2009.03.029;

Speed WC, Kang SP, Tuck DP, Harris LN, Kidd KK. Global variation in CYP2C8-CYP2C9 functional haplotypes. Pharmacogenomics J. 2009 Aug; 9(4):283-90. PMID: 19381162; PMCID: PMC2782405; DOI: 10.1038/tpj.2009.10;

Li A, Tuck D. An effective tri-clustering algorithm combining expression data with gene regulation information. Gene Regul Syst Bio. 2009 Apr 15; 3:49-64. PMID: 19838334; PMCID: PMC2758278; DOI: 10.4137/grsb.s1150;

Sarkar S, Tuck DP, Harris LN. Genomic analysis from tissue core biopsies: standard of care for the future? Breast Cancer Res Treat. 2009 Dec; 118(3):645-6. PMID: 19234784

Cheng EC, Luo Q, Bruscia EM, Renda MJ, Troy JA, Massaro SA, Tuck D, Schulz V, Mane SM, Berliner N, Sun Y, Morris SW, Qiu C, Krause DS. Role for MKL1 in megakaryocytic maturation. Blood. 2009 Mar 19; 113(12):2826-34. PMID: 19136660; PMCID: PMC2661865; DOI: 10.1182/blood-2008-09-180596;

Emerson JW, Dolled-Filhart M, Harris L, Rimm DL, Tuck DP. Quantitative assessment of tissue biomarkers and construction of a model to predict outcome in breast cancer using multiple imputation. Cancer Inform. 2009; 7:29-40. PMID: 19352457; PMCID: PMC2664700; DOI: 10.4137/cin.s911;

Moran MS, Yang Q, Harris LN, Jones B, Tuck DP, Haffty BG. Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer. Cancer. 2008 Nov 01; 113(9):2565-74. PMID: 18816610

Bruscia EM, Zhang PX, Ferreira E, Caputo C, Emerson JW, Tuck D, Krause DS, Egan ME. Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-/- mice. Am J Respir Cell Mol Biol. 2009 Mar; 40(3):295-304. PMID: 18776130; PMCID: PMC2645527; DOI: 10.1165/rcmb.2008-0170OC;

Tarafa G, Tuck D, Ladner D, Topazian M, Brand R, Deters C, Moreno V, Capella G, Lynch H, Lizardi P, Costa J. Mutational load distribution analysis yields metrics reflecting genetic instability during pancreatic carcinogenesis. Proc Natl Acad Sci U S A. 2008 Mar 18; 105(11):4306-11. PMID: 18337498; PMCID: PMC2393774; DOI: 10.1073/pnas.0708250105;

Mita AC, Olszanski AJ, Walovitch RC, Perez RP, MacKay K, Tuck DP, Simmons C, Hammond S, Mita MM, Beeram M, Stone AJ, Rowinsky EK, Lewis LD. Phase I and pharmacokinetic study of AI-850, a novel microparticle hydrophobic drug delivery system for paclitaxel. Clin Cancer Res. 2007 Jun 01; 13(11):3293-301. PMID: 17545535

Zhou X, Tuck DP. MSVM-RFE: extensions of SVM-RFE for multiclass gene selection on DNA microarray data. Bioinformatics. 2007 May 01; 23(9):1106-14. PMID: 17494773

Nakayama Y, Stabach P, Maher SE, Mahajan MC, Masiar P, Liao C, Zhang X, Ye ZJ, Tuck D, Bothwell AL, Newburger PE, Weissman SM. A limited number of genes are involved in the differentiation of germinal center B cells. J Cell Biochem. 2006 Dec 01; 99(5):1308-25. PMID: 16795035

Sung LY, Gao S, Shen H, Yu H, Song Y, Smith SL, Chang CC, Inoue K, Kuo L, Lian J, Li A, Tian XC, Tuck DP, Weissman SM, Yang X, Cheng T. Differentiated cells are more efficient than adult stem cells for cloning by somatic cell nuclear transfer. Nat Genet. 2006 Nov; 38(11):1323-8. PMID: 17013394

Cowan JD, Rimm DL, Tuck DP. Cruella: developing a scalable tissue microarray data management system. Arch Pathol Lab Med. 2006 Jun; 130(6):817-22. PMID: 16740033

Tuck DP, Kluger HM, Kluger Y. Characterizing disease states from topological properties of transcriptional regulatory networks. BMC Bioinformatics. 2006 May 02; 7:236. PMID: 16670008; PMCID: PMC1482723; DOI: 10.1186/1471-2105-7-236;

Kluger Y, Kluger H, Tuck D. Association between pathways in regulatory networks. Conf Proc IEEE Eng Med Biol Soc. 2006; 2006:2036-40. PMID: 17946929

Amin DN, Tuck D, Stern DF. Neuregulin-regulated gene expression in mammary carcinoma cells. Exp Cell Res. 2005 Sep 10; 309(1):12-23. PMID: 15963498

Kluger Y, Tuck DP, Chang JT, Nakayama Y, Poddar R, Kohya N, Lian Z, Ben Nasr A, Halaban HR, Krause DS, Zhang X, Newburger PE, Weissman SM. Lineage specificity of gene expression patterns. Proc Natl Acad Sci U S A. 2004 Apr 27; 101(17):6508-13. PMID: 15096607

Tsukahara Y, Lian Z, Zhang X, Whitney C, Kluger Y, Tuck D, Yamaga S, Nakayama Y, Weissman SM, Newburger PE. Gene expression in human neutrophils during activation and priming by bacterial lipopolysaccharide. J Cell Biochem. 2003 Jul 01; 89(4):848-61. PMID: 12858349

Lian Z, Kluger Y, Greenbaum DS, Tuck D, Gerstein M, Berliner N, Weissman SM, Newburger PE. Genomic and proteomic analysis of the myeloid differentiation program: global analysis of gene expression during induced differentiation in the MPRO cell line. Blood. 2002 Nov 01; 100(9):3209-20. PMID: 12384419

Ma X, Husain T, Peng H, Lin S, Mironenko O, Maun N, Johnson S, Tuck D, Berliner N, Krause DS, Perkins AS. Development of a murine hematopoietic progenitor complementary DNA microarray using a subtracted complementary DNA library. Blood. 2002 Aug 01; 100(3):833-44. PMID: 12130493

Tuck D, O'Connell R, Gershkovich P, Cowan J. An approach to object-relational mapping in bioscience domains. Proc AMIA Symp. 2002; 820-4. PMID: 12463939

Gianni L, Dombernowsky P, Sledge G, Martin M, Amadori D, Arbuck SG, Ravdin P, Brown M, Messina M, Tuck D, Weil C, Winograd B. Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancer. Ann Oncol. 2001 Aug; 12(8):1067-73. PMID: 11583187

Welles L, Saville MW, Lietzau J, Pluda JM, Wyvill KM, Feuerstein I, Figg WD, Lush R, Odom J, Wilson WH, Fajardo MT, Humphrey RW, Feigal E, Tuck D, Steinberg SM, Broder S, Yarchoan R. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma. J Clin Oncol. 1998 Mar; 16(3):1112-21. PMID: 9508198

Guha A, Tuck DP, Cone RE, Dainiak N. Induction of Erythropoiesis by MHC-Mediated Cognate Interactions between B- and T-Cells. Hematology. 1997; 2(1):29-38. PMID: 27406724

Tello R, Tuck D, Cosentino A. A system for automated procedure documentation. Comput Biol Med. 1995 Sep; 25(5):463-70. PMID: 8575161

Tuck DP, Cerretti DP, Hand A, Guha A, Sorba S, Dainiak N. Human macrophage colony-stimulating factor is expressed at and shed from the cell surface. Blood. 1994 Oct 01; 84(7):2182-8. PMID: 7919334

Bilgrami S, Almeida GD, Quinn JJ, Tuck D, Bergstrom S, Dainiak N, Poliquin C, Ascensao JL. Pancytopenia in allogeneic marrow transplant recipients: role of cytomegalovirus. Br J Haematol. 1994 Jun; 87(2):357-62. PMID: 7947279

Guha A, Mason RP, Chen L, Tuck DP, Dainiak N. Modulation of hematopoiesis by lymphocyte membrane-derived components. Leukemia. 1994 Apr; 8 Suppl 1:S227-30. PMID: 8152297

Guha A, Tuck D, Sorba S, Dainiak N. Expression of membrane-bound burst-promoting activity is mediated by allogeneic effector cells. Exp Hematol. 1993 Sep; 21(10):1335-41. PMID: 8359234

Morse EE, Tuck D, Ascensao J, Sorba S, Dainiak N. Factors affecting recovery after peripheral blood stem cell transplantation. Ann Clin Lab Sci. 1993 Mar-Apr; 23(2):89-96. PMID: 7681274

Tuck D, Silva M, Sorba S, Guha A, Abraham KI, Schochat D, Dainiak N. Inhibition of hematopoiesis in vitro with the Lym-1 monoclonal antibody. Ann N Y Acad Sci. 1991; 628:182-4. PMID: 2069299

Ershler WB, Tuck D, Moore AL, Klopp RG, Kramer KE. Immunologic enhancement of B16 melanoma growth. Cancer. 1988 May 01; 61(9):1792-7. PMID: 3258540

Lowenthal RM, Harlow RW, Mead AE, Tuck D, Challis DR. T-cell non-Hodgkin's lymphoma after radiotherapy and chemotherapy for Hodgkin's disease. Cancer. 1981 Oct 01; 48(7):1586-9. PMID: 6974586

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 75 publications over 30 distinct years, with a maximum of 7 publications in 2011

Bar chart showing 75 publications over 30 distinct years, with a maximum of 7 publications in 2011

Year	Publications
1981	1
1988	1
1991	1
1993	2
1994	3
1995	1
1997	1
1998	1
2001	1
2002	3
2003	1
2004	1
2005	1
2006	5
2007	2
2008	4
2009	6
2010	4
2011	7
2012	4
2013	4
2014	1
2015	2
2016	4
2017	2
2019	2
2020	1
2021	3
2022	4
2023	2

Contact for Mentoring:

820 Harrison Ave
Boston MA 02118
Google Map

781.491.4214

Download vCard

Tuck's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (431) concept(s)

Co-Authors

See all (11) people

Similar People

See all (60) people

Same Department

Search Department